OncLive® Scientific Interchange and Workshop Podcast Series: Treatment Updates in HER2+ Breast Cancer - Episode 3

Treatment of Metastatic HER2-Positive Breast Cancer

Dr Kaklamani and colleagues highlight key clinical trials such as DESTINY-Breast01, HER2CLIMB, NALA, and SOPHIA in the setting of advanced HER2-positive breast cancer and discuss the practical considerations of these data.